View Past PerformanceBluGlass バランスシートの健全性財務の健全性 基準チェック /56BluGlassの総株主資本はA$7.2M 、総負債はA$2.3Mで、負債比率は31.7%となります。総資産と総負債はそれぞれA$16.8MとA$9.7Mです。主要情報31.73%負債資本比率AU$2.27m負債インタレスト・カバレッジ・レシオn/a現金AU$2.98mエクイティAU$7.15m負債合計AU$9.69m総資産AU$16.84m財務の健全性に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct Listingお知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listingお知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australiaお知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Optionsお知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australiaお知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listingお知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.財務状況分析短期負債: BUGL.Fの 短期資産 ( A$8.2M ) が 短期負債 ( A$5.0M ) を超えています。長期負債: BUGL.Fの短期資産 ( A$8.2M ) が 長期負債 ( A$4.7M ) を上回っています。デット・ツー・エクイティの歴史と分析負債レベル: BUGL.F総負債よりも多くの現金を保有しています。負債の削減: BUGL.Fの負債対資本比率は、過去 5 年間で0%から31.7%に増加しました。貸借対照表キャッシュ・ランウェイ分析過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。安定したキャッシュランウェイ: BUGL.Fは、前回報告された フリーキャッシュフロー に基づいて4か月分の十分な キャッシュランウェイ を有していますが、その後追加の資本を調達しました。キャッシュランウェイの予測: BUGL.Fフリーキャッシュフロー 推定値 に基づいて4か月間十分なキャッシュランウェイがあると予測されていますが、その後、追加の資本を調達しました。健全な企業の発掘7D1Y7D1Y7D1YSemiconductors 業界の健全な企業。View Dividend企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/08 01:18終値2026/07/06 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋BluGlass Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Mark BryanCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.Darren VincentShaw and Partners Limited
お知らせ • Jun 02BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 1.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 5,769,230 Price\Range: AUD 0.26 Transaction Features: Subsequent Direct Listing
お知らせ • Apr 15BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 8.064 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 23,500,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 10,100,000 Price\Range: AUD 0.24 Discount Per Security: AUD 0.0144 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
お知らせ • Oct 18BluGlass Limited, Annual General Meeting, Nov 19, 2025BluGlass Limited, Annual General Meeting, Nov 19, 2025. Location: at the offices of automic group, level 5, 126 phillip street, sydney, nsw 2000 Australia
お知らせ • May 01+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 6 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 461,538,462 Price\Range: AUD 0.013 Discount Per Security: AUD 0.00026 Security Features: Attached Options
お知らせ • Sep 20BluGlass Limited, Annual General Meeting, Oct 21, 2024BluGlass Limited, Annual General Meeting, Oct 21, 2024. Location: at automic group offices, at level 5, 126 phillip street, sydney, nsw 2000. Australia
お知らせ • Apr 05BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 5.868146 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 157,842,057 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 756,489 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074
お知らせ • Feb 20BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has completed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,213 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Feb 12+ 1 more updateBluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million.BluGlass Limited has filed a Follow-on Equity Offering in the amount of AUD 4.3 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 116,216,216 Price\Range: AUD 0.037 Discount Per Security: AUD 0.00074 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 10BluGlass Limited Announces Management ChangesBluGlass Limited advised that Ms Elizabeth Spooner has resigned as Company Secretary of the Company. Ms Spooner will be replaced by Robyn Slaughter as Company Secretary with effect from 10 January 2024. Robyn is a Company Secretary who works closely with a number of boards of both listed and unlisted public companies across a range of industries including financial services, biotechnology and healthcare, technology, cyber security and manufacturing. Robyn is a qualified Governance Professional (CGI) and Affiliate of the Governance Institute of Australia (GIA), and holds a Master's degree in Corporate Governance and a Bachelor's degree in Accounting and Finance.
お知らせ • Sep 13Bluglass Limited Announces Executive ChangesBluGlass Limited has appointed Samuel Samhan as Chief Financial Officer on a full-time basis, effective 11 September 2023. Mr. Samhan is a highly credentialled senior executive with more than 20 years financial leadership and commercial operations experience. He was previously the Chief Operating and Financial Officer at Digital Wellness - a global health platform. Other roles include Head of Commercial and Business Transformation at Vitality Works - Sanitarium Workplace Health and Wellness, and Commercial Manager at Evolution Healthcare Group. He replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Mr. Ambrogio will remain with the Company until 29 September 2023. Mr. Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.
お知らせ • Sep 08BluGlass Limited, Annual General Meeting, Oct 09, 2023BluGlass Limited, Annual General Meeting, Oct 09, 2023, at 10:01 E. Australia Standard Time. Location: Grant Thornton, Level 17, 383 Kent Street Sydney New South Wales Australia Agenda: To receive and to consider the Annual Financial Report of the Company for the financial year ended 30 June 2023 together with the declaration of the Directors, the Directors' Report, the Remuneration Report and the Auditor's Report for that financial year; to consider Adoption of Remuneration Report; to consider re-election of Directors of the Company; to consider approval of Future Issue of Securities; to consider ratification of Prior Issue of Shares; to consider ratification of Prior Issue of Performance Rights; to consider ratification of Prior Issue of Options; to consider Adoption of Incentive Option & Performance Rights Plan; to consider approval of Issue of Performance Rights to James Walker, Vivek Rao, Stephe Wilks and Jean-Michel Pelaprat Directors of the Company; and to consider approval of Issue of Performance Rights.
お知らせ • Jan 30BluGlass Limited Launches Laser Product Suite at Photonics WestBluGlass Limited has launched its first suite of gallium nitride (GaN) laser products for customer purchase at leading industry conference, SPIE Photonics West, in San Francisco, USA. BluGlass' lasers are available across 405nm, 420nm, and 450nm wavelengths in both single-mode and multi-modedevices. Customers can inspect performance data and purchase these products in a range of form factors including TO Cans of different sizes and Chip-on-Submounts. BluGlass' suite of available products have passed entry-level commercial specifications following significant product development, optimisation, and performance and reliability testing. The following products are now available for customer purchase: Violet 405nm multi-mode 1W laser; Violet 405nm single-mode 250mW laser; Violet 420nm multi-mode 1W laser; Violet 420nm single-mode 250mW laser; Blue 450nm multi-mode 1W laser; Blue 450nm single-mode 100mW laser. The Company has received interest from customers wanting to deploy BluGlass lasers in their product development programs, which span a multitude of applications including; 3D printing, quantum sensing and computing, material sensing, and flow cytometry. In addition to the launched products, laser diode designs in other wavelengths and specifications are progressing through BluGlass' supply chain, including RPCVD-enhanced products.